Yefa Yang
Impact in
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
- Hepatology 31
- Hepatocellular Carcinoma Treatment and Prognosis 31
-
- Cancer Genomics and Diagnostics 2
- Co-authors
- Naijian Ge (24 shared papers)Zhengfeng Yin (4 shared papers)Jinliang Xing (7 shared papers)Feng Shen (7 shared papers)Haihua Qian (4 shared papers)Lu Yi Wu (6 shared papers)Mengchao Wu (6 shared papers)Lehua Shi (3 shared papers)
- Journals
- Liver Cancer (3 papers)Oncotarget (3 papers)Annals of Surgical Oncology (2 papers)PLoS ONE (2 papers)Cancer Science (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yefa Yang
42 papers receiving 1.8k citations
Yefa Yang's Hit Papers
Peers
Comparison fields: 5 of 66
- Hepatology 1.1k
- Cancer Research 215
- Endocrine and Autonomic Systems 46
- Oncology 142
- Radiology, Nuclear Medicine and Imaging 140
Countries citing papers authored by Yefa Yang
This map shows the geographic impact of Yefa Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yefa Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yefa Yang more than expected).
Fields of papers citing papers by Yefa Yang
This network shows the impact of papers produced by Yefa Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yefa Yang. The network helps show where Yefa Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yefa Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition) Hit paper breakdown → | 2020 | 619 |
| 2 | Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition) Hit paper breakdown → | 2023 | 309 |
| 3 | 2011 | 139 | |
| 4 | 2016 | 85 | |
| 5 | 2020 | 60 | |
| 6 | 2014 | 59 | |
| 7 | 2015 | 49 | |
| 8 | 2012 | 46 | |
| 9 | 2016 | 44 | |
| 10 | 2011 | 37 | |
| 11 | 2012 | 32 | |
| 12 | 2011 | 28 | |
| 13 | 2012 | 28 | |
| 14 | 2014 | 28 | |
| 15 | 2010 | 24 | |
| 16 | 2015 | 21 | |
| 17 | 2016 | 21 | |
| 18 | 2011 | 20 | |
| 19 | 2021 | 20 | |
| 20 | 2025 | 14 |
About Yefa Yang
Yefa Yang is a scholar working on Hepatology, Cancer Research, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Physiology, having authored 44 papers that have together received 1.8k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (31 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Abdominal vascular conditions and treatments (3 papers), Telomeres, Telomerase, and Senescence (3 papers), Mitochondrial Function and Pathology (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Cancer Genomics and Diagnostics (2 papers) and Gallbladder and Bile Duct Disorders (2 papers). The work is most often cited by research in Hepatology (1.1k citations), Cancer Research (215 citations), Endocrine and Autonomic Systems (46 citations), Oncology (142 citations) and Radiology, Nuclear Medicine and Imaging (140 citations). Yefa Yang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Naijian Ge, Zhengfeng Yin, Jinliang Xing, Feng Shen, Haihua Qian, Lu Yi Wu, Mengchao Wu, Lehua Shi, Hongxin Zhang and Han-Qiang Liu. Their work appears in journals such as Liver Cancer, Oncotarget, Annals of Surgical Oncology, PLoS ONE and Cancer Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.